Skip to content

Atherothrombotic aspects of cerebrovascular disease

Atherothrombotic profile of cerebrovascular disease: prospective cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-5v3sspr
Enrollment
Unknown
Registered
2023-07-30
Start date
2022-01-31
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid stenosis

Interventions

Group of 45 participants with carotid stenotic disease screened in vascular surgery clinics and followed for 12 months. Identify the current practice of cardiovascular risk reduction strategies for th

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunteers with asymptomatic or symptomatic extracranial carotid stenosis, both genders, minimum age of 18 years.

Exclusion criteria

Exclusion criteria: Restenosis after previous treatment of carotid endarterectomy or carotid angioplasty in the artery of interest; Inability to sign an informed consent form; Life expectancy less than 6 months; Advanced dementia; Severe kidney failure.

Design outcomes

Primary

MeasureTime frame
Evaluate the progression of cerebrovascular atherothrombotic disease, determined through vascular Doppler at the beginning of the study and with qualitative variables described as number and percentage and the quantitative ones will be described as mean +- standard deviation or as median, 25th percentile and 75th percentile . ;Identify the proportion of research participants who at the initial visit are using the cardiovascular risk reduction strategies that will be analyzed through qualitative variables and described as number and percentage and the quantitative ones will be described as mean +- standard deviation or as median.

Secondary

MeasureTime frame
Evaluate major cardiovascular events that will be followed up over a period of 12 months and analyzed using the McNemar chi-square test.;Evaluate the adherence of the participants in relation to the treatment already recommended and the proportions and respective 95% confidence intervals (95% CI) will be estimated.

Countries

Brazil

Contacts

Public ContactLuis Nakano

universidade federal de são paulo

luicnakano+1@uol.com.br+55(11)55764848

Outcome results

None listed

Source: REBEC (via WHO ICTRP)